Targeting the IRE1α-XBP1s axis confers selective vulnerability in hepatocellular carcinoma with activated Wnt signaling

• Published in: Oncogene 2024-04, Vol.43 (17), p.1233-1248
• Main Authors: Zhang, Tingting, Zhao, Faming, Zhang, Yi, Shi, Ji-Hua, Cui, Fengzhen, Ma, Weixiang, Wang, Kai, Xu, Chuanrui, Zeng, Qingping, Zhong, Rong, Li, Ningning, Liu, Yong, Jin, Yang, Sheng, Xia
• Format: Article
• Language: English
• Subjects: 13/105; 13/44; 13/51; 14/1; 38; 38/89; 38/91; 631/67/1504/1610; 631/80/470/1463; 64/60; Animal models; Apoptosis; Cell Biology; Cell survival; Explants; Hepatocellular carcinoma; Human Genetics; Internal Medicine; Liver cancer; Medical prognosis; Medicine; Medicine & Public Health; Oncology; Tumors; Wnt protein; β-Catenin
• ISSN: 0950-9232; 1476-5594
• DOI: 10.1038/s41388-024-02988-4

Liver-specific Ern1 knockout impairs tumor progression in mouse models of hepatocellular carcinoma (HCC). However, the mechanistic role of IRE1α in human HCC remains unclear. In this study, we show that XBP1s, the major downstream effector of IRE1α, is required for HCC cell survival both in vitro and in vivo. Mechanistically, XBP1s transactivates LEF1, a key co-factor of β-catenin, by binding to its promoter. Moreover, XBP1s physically interacts with LEF1, forming a transcriptional complex that enhances classical Wnt signaling. Consistently, the activities of XBP1s and LEF1 are strongly correlated in human HCC and with disease prognosis. Notably, selective inhibition of XBP1 splicing using an IRE1α inhibitor significantly repressed the viability of tumor explants as well as the growth of tumor xenografts derived from patients with distinct Wnt/LEF1 activities. Finally, machine learning algorithms developed a powerful prognostic signature based on the activities of XBP1s/LEF1. In summary, our study uncovers a key mechanistic role for the IRE1α-XBP1s pathway in human HCC. Targeting this axis could provide a promising therapeutic strategy for HCC with hyperactivated Wnt/LEF1 signaling.